Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University Research & Clinical Trial Webinars,Webinars 13 years ago You may also like 1:01:24 Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024] 3 months ago Webinars 1:00:59 Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients 4 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:05:32 Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy 4 months ago Research & Clinical Trial Webinars,Webinars edgewise 58:10 Webinar: Community Progress in Duchenne Newborn Screening 7 months ago Webinars feature,newborn screening 1:01:30 Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat) 9 months ago Research & Clinical Trial Webinars,Webinars duvyzat,feature,givinostat,itf therapeutics 45:03 Webinar: Sarepta Therapeutics – Data update from MOMENTUM study, SRP-5051 9 months ago Research & Clinical Trial Webinars,Webinars sarepta 39:33 Webinar: NS Pharma – Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03 9 months ago Research & Clinical Trial Webinars,Webinars ns pharma 52:15 Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences 10 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 «1234…25»Page 2 of 25
by: Parent Project Muscular Dystrophy
![Webinar: PPMD Advocacy - Raising Our Voices in 2024 and Beyond [Sep 2024]](https://img.youtube.com/vi/sHbI1e3yNdw/maxresdefault.jpg)
